Autor/in Pieters, R 4 den Boer, M L Escherich, G 2 Horstmann, M A 2 Janka-Schaub, Gritta 2 van Wering, E R 2 Ariës, I M 1 Beverloo, H B 1 Boer, J M 1 Hall, A G 1 Harbott, J 1 Hoelzer, D 1 Hoogeveen, P G 1 Irving, J A E 1 Jerchel, I S 1 Loonen, A H 1 Ludwig, W-D 1 Meier, M 1 Minto, L 1 Ossenkoppele, G J 1 Passier, M 1 Petricoin, E F 1 Ramakers-van Woerden, N L 1 Slater, R M 1 Willemse, M E 1 van den Berk, L C J 1 van den Dungen, R E S R 1 van der Veer, A 1 van der Velden, V H J 1 alle zeigenListe einklappen
Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia van der Veer, A van der Velden, V H J Willemse, M E Hoogeveen, P G Petricoin, E F Beverloo, H B Escherich, G 2014 - Forschungsinformationssystem des UKE
EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion Ariës, I M Jerchel, I S van den Dungen, R E S R van den Berk, L C J Boer, J M Horstmann, M A Escherich, G 2014 - Forschungsinformationssystem des UKE
Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia. Meier, M den Boer, M L Hall, A G Irving, J A E Passier, M Minto, L van Wering, E R 2005 - Forschungsinformationssystem des UKE
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups. Ramakers-van Woerden, N L Pieters, R Hoelzer, D Slater, R M den Boer, M L Loonen, A H Harbott, J 2002 - Forschungsinformationssystem des UKE